1,3-OXATHIOLANE NUCLEOSIDE ANALOGUES IN THE TREATMENT OF HEPATITIS C - Patent 0844878

(19)

(11)

EP 0 844 878 A1

(12)

(43)	Date of publication:
	03.06.1998 Bulletin 1998/23

(21)	Application number: 96930043.0

(22)	Date of filing: 16.08.1996

(51)

International Patent Classification (IPC):

C07D 411/ 04^{( . )}
A61K 31/ 00^{( . )}
A61K 31/ 506^{( . )}
A61K 45/ 00^{( . )}
A61P 31/ 12^{( . )}

A61F 13/ 20^{( . )}
A61K 31/ 505^{( . )}
A61K 31/ 513^{( . )}
A61P 31/ 00^{( . )}

(86)	International application number:
	PCT/EP1996/003601

(87)	International publication number:
	WO 1997/006804 (27.02.1997 Gazette 1997/10)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV SI

(30)

Priority:

19.08.1995 GB 19950017022

(71)	Applicant: GLAXO GROUP LIMITED
	Greenford, Middlesex UB6 0NN (GB)

(72)	Inventor:
	McDADE, Hugh Brownlie, Glaxo Wellcome plc Greenford, Middlesex UB6 0HE (GB)

(74)	Representative: Quillin, Helen Kaye, et al
	Glaxo Wellcome plc Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN Greenford, Middlesex UB6 0NN (GB)

(54)	1,3-OXATHIOLANE NUCLEOSIDE ANALOGUES IN THE TREATMENT OF HEPATITIS C